Product Information
CRYSELLE-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2908 per EA under NDC 00480349316. Its NADAC has been published 22 times since Jan 28, 2026.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480349316
Classification
Generic
Dosage Form
KIT
Route
ORAL
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075840On Market Since
12/12/2025
Price Statistics
The NADAC for CRYSELLE-28 TABLET has been published 22 times since Jan 28, 2026, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2908 per EA |
|---|---|
| All-time high | $0.3538 (Feb 11, 2026) |
| All-time low | $0.2908 (Jun 17, 2026) |
| 52-week high | $0.3538 |
| 52-week low | $0.2908 |
| Median price | $0.3023 |
| Average price | $0.3113 |
| Largest weekly change | -8.7% (Feb 18, 2026) |
| Weeks tracked | 22 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CRYSELLE-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRYSELLE-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2908 per EA (NDC 00480349316), effective Jun 24, 2026.
How has the price of CRYSELLE-28 TABLET changed over time?
Over the history we have for it, the NADAC for CRYSELLE-28 TABLET has declined 17.8%. It has been tracked across 22 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for CRYSELLE-28 TABLET?
Since Jan 28, 2026, the NADAC for CRYSELLE-28 TABLET has ranged from a low of $0.2908 (Jun 17, 2026) to a high of $0.3538 (Feb 11, 2026), with a median of $0.3023 per EA.
Are there cheaper alternatives to CRYSELLE-28 TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CRYSELLE-28 TABLET, but none are currently priced below it.
Who manufactures CRYSELLE-28 TABLET?
CRYSELLE-28 TABLET (NDC 00480349316) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification